Genoco-Giant Staff demand forecasting to come along with the box office… Does the public offering craze continue?

With a margin of close to 64 trillion won in SK Bioscience’s general subscription, demand forecasting continues to be a box office craze.

According to the financial investment industry on the 14th, Genoko’s demand forecast competition rate, which took place on the 9th to 10th, recorded 1452:1. Most of the participants applied for more than the desired range (27,000 won to 33,000 won), and the public offering price was confirmed at 36,000 won. It was found that 90.63% of the applicants offered more than 36,000 won.

Genoko is a specialized aerospace communication company established in 2004. Satellite communication-related parts, such as satellite mounts and satellite ground stations, are mainly produced. Currently, it is preparing to list on the KOSDAQ as a special technology listing. It is scheduled to enter the KOSDAQ on the 24th after the general subscription on the 15th to the 16th. The total number of publicly offered shares is 490,000.

Giant Step, a visual effects (VFX) specialist, which carried out demand forecasting during the same period, also set a new record for the highest competition rate for demand forecasting. As a result of the demand forecast for institutional investors, the competition rate was 1691.65:1.

The public offering price was decided at 11,000 won, the top of the desired range (9,000 won to 11,000 won). 1627 domestic and foreign organizations participated in the demand forecasting, of which 1569, or 96%, offered prices that exceeded the desired range.

Giant Step is focusing on content and advertisement production as its main business unit. It has carried out projects such as Naver and Samsung Electronics, and is establishing cooperative relationships with advertising agencies such as Cheil Worldwide. The subscription for general investors is scheduled to be implemented on the 15th to 16th. The total public offering amount is 15.4 billion won.